Absent signs, symptoms suggesting etiology, clinicians rely on inflammatory markers, imaging to make the diagnosis
Rheumatology Research Foundation Shares Excitement about Specialty with Medical Students, Residents
Foundation’s Student and Resident Experience event at the ACR/ARHP annual meeting encourages students to pursue career in rheumatology
Rheumatology Fellows-in-Training Offer Fresh Perspectives on the ACR/ARHP Annual Meeting
Medical residents relay insights on annual meeting sessions, lectures, networking events, and Boston tourism
The ACR Advocates for Drug Coverage, Payment Policies to Protect Rheumatology Patients, Practices
Rheumatologists must be adequately compensated for managing patients with complex drug therapies and Medicare beneficiaries need access to biologic treatments
2014 ACR/ARHP Annual Meeting: Lung Fibrosis
New drugs, targeted treatments for idiopathic pulmonary fibrosis
New Compound Promotes Recovery from Spinal Cord Injury
Research suggests delivery of protein peptide can restore serotonergic innervation to spinal cord below level of injury; facilitate recovery of locomotor and urinary system function
Hepatitis C Virus Infection Associated with Rheumatoid Arthritis
Research finds patients with chronic HCV infection more likely to develop RA, especially men
Shorter Antibiotic Therapy Effective for Pyogenic Vertebral Osteomyelitis
Six-week treatment regimen returns same results as 12 weeks in recent study, although researchers caution findings may not apply to all patients with vertebral osteomyelitis
Genetic Risk Factors for Rheumatoid Arthritis Merit More Research
New report determines additional risk factors need to be identified, studied before RA heritability can be fully explained
2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News
Plus, hydrocodone combination products and brodalumab
- « Previous Page
- 1
- …
- 206
- 207
- 208
- 209
- 210
- …
- 301
- Next Page »